Patients considering Retatrutide as part of their metabolic health plan benefit most from open, ongoing communication with their provider about how their body is responding at each stage, rather than focusing on a specific number as the end goal
Common side effects: Nausea Vomiting Diarrhea Constipation Reduced appetite Serious but rare side effects: Pancreatitis Gallbladder issues Severe allergic reactions Some studies suggest Mounjaro may cause slightly stronger digestive side effects , especially during the first few weeks, but many patients tolerate it well after dose adjustment
Some lighter individuals find their sweet spot at 5-7.5 mg
In the SUMMIT trial, decreases in estimated BV at 52 weeks (potentially related to the suppression of adipocytokines) were associated with reduction in albuminuria, but we observed no relationship with the improvements in eGFR
Clinical Logic: In such cases, GLP-1 therapy should be introduced early as an adjunct to LSM rather than a last-resort measure